Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Danielle Sullivan

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Health Care Transitions|December 23, 2024
Pediatric to adult primary care transition for medically complex youth: A tale of learning from challenges experienced implementing a pilot project during COVID-19Reem Hasan, Reyna Lindert, Danielle Sullivan, et al.
Archives of Women'S Mental Health|August 7, 2013
Association study of the estrogen receptor gene ESR1 with postpartum depression--a pilot studyJulia K Pinsonneault, Danielle Sullivan, Wolfgang Sadee, et al.
Neuroscience Research|November 24, 2016
Valley of death: A proposal to build a "translational bridge" for the next generationNao J Gamo, Michelle R Birknow, Danielle Sullivan, et al.
Contemporary Clinical Trials|August 19, 2017
Dose-ranging design and analysis methods to identify the minimum effective dose (MED)Yijie Zhou, Su Chen, Danielle Sullivan, et al.
AEM Education and Training|June 14, 2021
A novel program to enhance pediatric emergency medicine training in ThailandBeech Burns, Jessica Bailey, Melinda Hartenstein, et al.
Gynecologic Oncology|January 21, 2018
Phase I combination study of the PARP inhibitor veliparib plus carboplatin and gemcitabine in patients with advanced ovarian cancer and other solid malignanciesHeidi J Gray, Katherine Bell-McGuinn, Gini F Fleming, et al.
Cancer Medicine|May 8, 2018
Safety and pharmacokinetics of veliparib extended-release in patients with advanced solid tumors: a phase I studyTheresa L Werner, Jasgit Sachdev, Elizabeth M Swisher, et al.
Gynecologic Oncology|June 11, 2021
Progression-free survival by investigator versus blinded independent central review in newly diagnosed patients with high-grade serous ovarian cancer: Analysis of the VELIA/GOG-3005 trialCarol Aghajanian, Michael A Bookman, Gini F Fleming, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 30, 2016
Liver Microvascular Injury and Thrombocytopenia of Antibody-Calicheamicin Conjugates in Cynomolgus Monkeys-Mechanism and MonitoringMagali Guffroy, Hadi Falahatpisheh, Kathleen Biddle, et al.
Anesthesiology|January 13, 2025
TAK-925 (Danavorexton), an Orexin Receptor 2 Agonist, Reduces Opioid-induced Respiratory Depression and Sedation without Affecting Analgesia in Healthy MenMaarten van Lemmen, Albert Dahan, Yaming Hang, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Health Care Transitions|December 23, 2024
Pediatric to adult primary care transition for medically complex youth: A tale of learning from challenges experienced implementing a pilot project during COVID-19Reem Hasan, Reyna Lindert, Danielle Sullivan, et al.
Archives of Women'S Mental Health|August 7, 2013
Association study of the estrogen receptor gene ESR1 with postpartum depression--a pilot studyJulia K Pinsonneault, Danielle Sullivan, Wolfgang Sadee, et al.
Neuroscience Research|November 24, 2016
Valley of death: A proposal to build a "translational bridge" for the next generationNao J Gamo, Michelle R Birknow, Danielle Sullivan, et al.
Contemporary Clinical Trials|August 19, 2017
Dose-ranging design and analysis methods to identify the minimum effective dose (MED)Yijie Zhou, Su Chen, Danielle Sullivan, et al.
AEM Education and Training|June 14, 2021
A novel program to enhance pediatric emergency medicine training in ThailandBeech Burns, Jessica Bailey, Melinda Hartenstein, et al.
Gynecologic Oncology|January 21, 2018
Phase I combination study of the PARP inhibitor veliparib plus carboplatin and gemcitabine in patients with advanced ovarian cancer and other solid malignanciesHeidi J Gray, Katherine Bell-McGuinn, Gini F Fleming, et al.
Cancer Medicine|May 8, 2018
Safety and pharmacokinetics of veliparib extended-release in patients with advanced solid tumors: a phase I studyTheresa L Werner, Jasgit Sachdev, Elizabeth M Swisher, et al.
Gynecologic Oncology|June 11, 2021
Progression-free survival by investigator versus blinded independent central review in newly diagnosed patients with high-grade serous ovarian cancer: Analysis of the VELIA/GOG-3005 trialCarol Aghajanian, Michael A Bookman, Gini F Fleming, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 30, 2016
Liver Microvascular Injury and Thrombocytopenia of Antibody-Calicheamicin Conjugates in Cynomolgus Monkeys-Mechanism and MonitoringMagali Guffroy, Hadi Falahatpisheh, Kathleen Biddle, et al.
Anesthesiology|January 13, 2025
TAK-925 (Danavorexton), an Orexin Receptor 2 Agonist, Reduces Opioid-induced Respiratory Depression and Sedation without Affecting Analgesia in Healthy MenMaarten van Lemmen, Albert Dahan, Yaming Hang, et al.
Pageof 2